Meeting
2014 ASCO Annual Meeting
Second-line chemotherapy for advanced biliary tract cancer after failure of gemcitabine plus platinum: Results of an AGEO multicenter retrospective study.
Authors
Bertrand Brieau
Hôpital Cochin, Paris, France
Bertrand Brieau , Laetitia Dahan , Yann De Rycke , Tarek Boussaha , Philippe Vasseur , David Tougeron , Thierry Lecomte , Romain Coriat , Jean Baptiste Bachet , Pierre Claudez , Aziz Zaanan , Pauline Soibinet , Jérôme Desramé , Anne Thirot-Bidault , Isabelle Trouilloud , Florence Mary , Christophe Locher , Lysiane Marthey , Wulfran Cacheux , Astrid Lievre
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 4093)
DOI
10.1200/jco.2014.32.15_suppl.4093
Abstract #
4093
Poster Bd #
180
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2022 ASCO Annual Meeting
A descriptive study on the treatment and outcomes of patients with platinum-sensitive, advanced, BRCA- or PALB2-related pancreatic cancer who have progressed on rucaparib.
First Author: Timothy J Brown
Poster
2021 ASCO Annual Meeting
Association of cell-free DNA dominant clone allele frequency with poor outcomes in advanced biliary cancers treated with platinum-based chemotherapy.
First Author: Umair Majeed
Poster
2016 Gastrointestinal Cancers Symposium
Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.
First Author: Maeve Aine Lowery